Published Date: 02 Mar 2023
High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.
Read Full NewsPatient presented with what was assumed to be rotator cuff injury
Consistently low PSA levels failed to signal metastasis
— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease
1.
CAR-T for Chronic Lymphocytic Leukemia Receives FDA Approval.
2.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
3.
PSA Screening May Modestly Curb Prostate Cancer Deaths
4.
Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.
5.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
1.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
2.
Understanding Mean Corpuscular Volume: A Comprehensive Guide
3.
Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy
4.
Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management
5.
Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
2.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation